Melanoma News and Research

Latest Melanoma News and Research

Melanoma could soon be detected using a blood test

West Australian researchers from Edith Cowan University have managed to develop a blood test that is capable of diagnosing melanomas before they can spread to other parts of the body. The study titled, “A diagnostic autoantibody signature for primary cutaneous melanoma,” was published in the latest issue of the journal Oncotarget.

18 Jul 2018

Can-Fite BioPharma receives Australian and Chinese patents for new drug to treat erectile dysfunction

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address liver diseases, inflammatory diseases and sexual dysfunction, today announced that the Australian and Chinese patent offices have granted the Company a patent for the utilization of A3 adenosine receptor ligands in the treatment of sexual dysfunction, in a patent (Australian, No. 2013301125ZL, Chinese No. 2013800472970) titled, "A3 adenosine receptor ligands for use in treatment of a sexual dysfunction."

17 Jul 2018

Researchers reduce size of tumors in mice by artificially activating the brain's reward system

By artificially activating the brain's reward system, researchers at the Technion-Israel Institute of Technology have dramatically reduced the size of cancerous tumors in mice. The findings were published recently in the journal Nature Communications.

16 Jul 2018

'Skin Cancer, Take A Hike!' program promotes sun safety and skin cancer awareness

Skin cancer is the most common cancer in the United States, affecting one in five Americans in their lifetime.

13 Jul 2018

Immunotherapies may increase overall survival in patients with melanoma brain metastases

Among patients with cutaneous melanoma who had brain metastases (MBM), first-line treatment with a checkpoint inhibitor was associated with a 1.4-fold increase in median overall survival, according to results from a national cohort.

13 Jul 2018

Researchers discover critical link in mapping recurrent mutations of melanoma

A critical link in mapping recurrent mutations of melanoma -- the most serious form of skin cancer in humans -- has been discovered by researchers at Washington State University School of Molecular Biosciences, in collaboration with researchers at Georgia State University.

6 Jul 2018

Study reviews accuracy, benefits, limitations of apps used for skin cancer diagnosis

In the scramble to bring successful apps for the diagnosis of skin cancer to market there is a concern that a lack of testing is risking public safety, according to research led by the University of Birmingham.

5 Jul 2018

Sun avoidance may be almost as hazardous to health as cigarette smoking

Available on Amazon, Embrace the Sun, by authors Marc B. Sorenson, Ed.D.and William B. Grant, Ph.D.,claim that sun avoidance may be nearly as hazardous to your health as cigarette smoking!

3 Jul 2018

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced that U.S. researchers published scientific findings recommending development of anti-Liver Cancer Drugs based on a mechanism of action utilized by Namodenoson.

2 Jul 2018

Cilia appears to play key role in formation of melanoma

Most cells in the human body have a cilium, a slender cell protuberance that picks up signals from the cell's external environment.

2 Jul 2018

New computational method improves ability to track spread of cancer cells

Princeton researchers have developed a new computational method that increases the ability to track the spread of cancer cells from one part of the body to another.

30 Jun 2018

Research shows why new cancer therapies fail to work on some patients

University of Otago research provides insights into an underlying mechanism that could explain why new cancer therapies to help treat metastatic melanoma do not always work on patients, paving the way for predicting which patients will benefit from certain drugs.

30 Jun 2018

A small molecule can inhibit chemotherapy resistance of certain tumors

A team of researchers from the CNRS and Université Nice Sophia Antipolis has just shown that a small molecule called methiothepin can inhibit the chemotherapy resistance of certain tumors.

28 Jun 2018

Educational intervention increases sunscreen use, reduces sunburns among operating engineers

Implementation of educational interventions among operating engineers in Michigan significantly increased the use of sunscreen and decreased the number of reported sunburns.

28 Jun 2018

Salk Institute scientists receive funding for cancer research

Salk Institute scientists Ronald Evans, Diana Hargreaves, Tony Hunter, Graham McVicker and Geoffrey Wahl are among the first wave of researchers to receive funding from Padres Pedal the Cause, one of one of the largest stand-alone cancer fundraising events in San Diego.

27 Jun 2018

New avenue for cancer treatment opens when one drug fails

A new class of cancer drugs – called CDK4/6 inhibitors -- recently approved to treat breast cancer can stunt the cancer's growth and replication.

27 Jun 2018

Phase 1 clinical trial of poliovirus therapy shows long-term survival benefit for recurrent glioblastoma

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rate of 21 percent in a phase 1 clinical trial.

26 Jun 2018

Study shows increased risk of cancer among US flight attendants

A new study from Harvard T.H. Chan School of Public Health has revealed that several types of cancer are more common among US flight attendants than they are among the general population.

26 Jun 2018

Novel smart probe may improve post-surgical outcomes for cancer patients

A new Tel Aviv University study explores a novel smart probe for image-guided surgery that may dramatically improve post-surgical outcomes for cancer patients.

26 Jun 2018

Researchers discover immune profile for effective cancer immunotherapy

In a new study published online June 25, 2018 in Nature Medicine, UC San Francisco researchers have identified a key biological pathway in human cancer patients that appears to prime the immune system for a successful response to immunotherapy drugs known as checkpoint inhibitors.

25 Jun 2018

Melanoma News and Research

Latest Melanoma News and Research

Melanoma could soon be detected using a blood test

Can-Fite BioPharma receives Australian and Chinese patents for new drug to treat erectile dysfunction

Researchers reduce size of tumors in mice by artificially activating the brain's reward system

'Skin Cancer, Take A Hike!' program promotes sun safety and skin cancer awareness

Immunotherapies may increase overall survival in patients with melanoma brain metastases

Researchers discover critical link in mapping recurrent mutations of melanoma

Study reviews accuracy, benefits, limitations of apps used for skin cancer diagnosis

Sun avoidance may be almost as hazardous to health as cigarette smoking

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Cilia appears to play key role in formation of melanoma

New computational method improves ability to track spread of cancer cells

Research shows why new cancer therapies fail to work on some patients

A small molecule can inhibit chemotherapy resistance of certain tumors

Educational intervention increases sunscreen use, reduces sunburns among operating engineers

Salk Institute scientists receive funding for cancer research

New avenue for cancer treatment opens when one drug fails

Phase 1 clinical trial of poliovirus therapy shows long-term survival benefit for recurrent glioblastoma

Study shows increased risk of cancer among US flight attendants

Novel smart probe may improve post-surgical outcomes for cancer patients

Researchers discover immune profile for effective cancer immunotherapy

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Melanoma News and Research

Latest Melanoma News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in